Vertex Pharmaceuticals Inc. buy Morgan Stanley
Start price
13.02.26
/
50%
€420.00
Target price
13.02.27
-
Performance (%)
-11.39%
Price
10.04.26
€372.15
Summary
This prediction is currently active. The prediction for Vertex Pharmaceuticals Inc. disappoints with a performance of -11.39%. This prediction currently runs until 13.02.27. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | -2.156% | -2.156% |
| iShares Core DAX® | 2.554% | -0.112% |
| iShares Nasdaq 100 | 2.742% | -0.470% |
| iShares Nikkei 225® | 6.584% | 3.221% |
| iShares S&P 500 | 1.930% | -0.519% |
Comments by Morgan_Stanley for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Morgan_Stanley for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€371.55
10.04.26
10.04.26
€523.50
10.04.27
10.04.27
0.16%
10.04.26
10.04.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€429.85
10.03.26
10.03.26
€512.68
10.03.27
10.03.27
-13.42%
10.04.26
10.04.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€375.90
03.12.25
03.12.25
€443.40
03.12.26
03.12.26
-1.00%
10.04.26
10.04.26